SlideShare a Scribd company logo
1 of 14
A dangerous trend in the USA




                               1
Headache

           Fever


                                 Blisters                   Tiredness




              Itching

                                                       Chicken pox
                         Sore                           (Varicella)
                        throat




                                                                        22
http://www.cdc.gov
American parents’ first reaction




                               3
USA - Before 1995

                                                                                                        Each year
                  4 million people would get the
                            chicken pox


              About 10,500 – 13,000 were
                     hospitalized                                                                   Majority :
                                                                                                     healthy
                                                                                                   children and
                            100 to 150 died                                                           adults

http://www.cdc.gov                                                                                                  4
Walter A., Orenstein M.D., National Immunization Program. Overview of the US Vaccination Program
Why a VZV vaccine?

       Varicella develops in nearly all persons living in the US
            • > 90% of adults immune to VZV

       Complications rate higher for persons ≥ 15 and < 1 years of age
            • Bacterial infection of skins lesions, pneumonia, dehydratation, encephalitis, hepatitis

       VZV vaccine licensed in several European countries (1984), Japan (1986), Korea (1988)
            • No safety concerns after the administration of > 2 million doses in these countries

       Varicella is less severe among vaccinated persons than unvaccinated persons
            • Afebrile, fewer vesicular lesions, shorter duration of illness

       Difference of incidence of herpes zoster
            • 18 per 100000 persons/year for vaccinated people
            • 77 per 100000 persons/year after natural Varicella
                                                                                                                      5
MMWR, Advisory Committee on Immunization Practices (ACIP). Prevention of Varicella. July 12, 1996, Vol 45, No RR-11
Cost-effectiveness of a Routine Varicella
                                 Vaccination program for US children


                   One dose/child under 6                                         30-year period following introduction
                             $35/dose                                        At school entry, vaccination coverage level =
                                                                                         97% by the 6th year


                          Medical costs                                                            Work-loss costs
           • Varicella treatment : Acyclovir                                  • Parents missing work when their children
          • Vaccinated people : no Acyclovir                                          have the chickenpox ($201)
                   • Complications                                                  • Adults contracting chickenpox


                                                           Taking into account
                                     • Evidence about vaccine efficacy
                   • Effects of expected changes in the age distribution of the disease
              • Empirical data on the costs of medical utilization and work loss from varicella
                                                                                                                                   6
Lieu, Tracy A et al. Cost-effectiveness of a Routine Varicella Vaccination program for US Children. JAMA; 1994; 271 (5), 375-381
Cost-effectiveness of a Routine Varicella
                                 Vaccination program for US children




                                                                                                                                   7
Lieu, Tracy A et al. Cost-effectiveness of a Routine Varicella Vaccination program for US Children. JAMA; 1994; 271 (5), 375-381
Cost-effectiveness of a Routine Varicella
                                 Vaccination program for US children




          Savings from Varicella disease prevention :                                $1.3 billion for the 1-dose program,
                                                                                     $1.4 billion for the 2-dose program.
                                                                                                                                   8
Lieu, Tracy A et al. Cost-effectiveness of a Routine Varicella Vaccination program for US Children. JAMA; 1994; 271 (5), 375-381
99
Recommendation map




                Kg: Kindergarten
                Gr: School Grade
Effects of vaccination




     Hospitalization rate: 2.2 to 3.3/100.000 (1995-1998) to 0.5/100.000 (2004)
Death rate: 0.41 deaths/1,000,000 (1990-1994) to 0.14 (1999-2001) (decrease of 78%)
The other hand


                              FEAR


                         Not natural

                         Side effects

•Mild : fever (≤1/10), rash (1/25)
•Moderate: Seizure (jerking/staring) caused by fever (very rare)
•Severe: pneumonia
The French point of view

     Same incidence, same complications, same risks…
         BUT vaccine only recommended in certain cases, if no varicella history:
         •Vaccination within 3 days following exposure (adults & immunocompetent)
         •Health care workers
         •Contact with young children & immunodeficient people
         •Children organ recipient

     Considering that: 15 years of vaccine coverage of children of 11 years-old is necessary to
     save:
         •1 death
         •30 severe complications
         •30.000 cases/year (nowadays incidence is about 600.000 cases/year)

     Plus:
         •increasing of the disease in the teenage and adult population
         •Increasing of zoster outcomes in the senior population.
HAS: AVIS DU CONSEIL SUPÉRIEUR D'HYGIÈNE PUBLIQUE DE FRANCE
SECTION MALADIES TRANSMISSIBLES
Relatif à la vaccination contre la varicelle
“ils sont fous ces américains”

 New drifts :
Mailing/selling infected clothes, saliva samples, infected lollipops...
   Risk of 20 years of imprisonment: under biohazard regulation (like anthrax)
   Danger for workers of mailing companies




Looking for more dangerous diseases:

   Measles, mumps…

More Related Content

What's hot

Vaccination in chronic children
Vaccination in chronic childrenVaccination in chronic children
Vaccination in chronic childrenWAidid
 
Seminar adult immunization
Seminar   adult immunizationSeminar   adult immunization
Seminar adult immunizationAbhay Dhanorkar
 
Immunisatiion during pregnancy and post partum period
Immunisatiion during pregnancy and  post partum  periodImmunisatiion during pregnancy and  post partum  period
Immunisatiion during pregnancy and post partum periodShivamurthy Hm
 
Vaccinations in pregnancy
Vaccinations in pregnancyVaccinations in pregnancy
Vaccinations in pregnancyMocte Salaiza
 
Prevention and vaccine pediatrics for clinical pharmacy
Prevention and vaccine pediatrics for clinical pharmacyPrevention and vaccine pediatrics for clinical pharmacy
Prevention and vaccine pediatrics for clinical pharmacyHussein Abdeldayem
 
Adult immunisation
Adult immunisationAdult immunisation
Adult immunisationDR RML DELHI
 
Vaccination and pregnancy
Vaccination and pregnancy Vaccination and pregnancy
Vaccination and pregnancy Salam Khassaf
 
Vaccination in pregnancy-DR.DIVYA JAIN
Vaccination in pregnancy-DR.DIVYA JAINVaccination in pregnancy-DR.DIVYA JAIN
Vaccination in pregnancy-DR.DIVYA JAINDrMaishu Jain
 
AAC Family Wellness (NY) - Vaccine Talk 2014
AAC Family Wellness (NY) - Vaccine Talk 2014AAC Family Wellness (NY) - Vaccine Talk 2014
AAC Family Wellness (NY) - Vaccine Talk 2014stellablue
 
immunization
immunizationimmunization
immunizationssn zhd
 
Priya early childhood immunization programs
Priya early childhood immunization programsPriya early childhood immunization programs
Priya early childhood immunization programsrsbkh
 
Universal Immunization Program 2017
Universal Immunization Program 2017Universal Immunization Program 2017
Universal Immunization Program 2017Annu verma
 
Epi seminar
Epi seminarEpi seminar
Epi seminarjarati
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseasesShirish Tiwari
 
Polio eradication program
Polio eradication programPolio eradication program
Polio eradication programbhabilal
 
Vaccination of pregnant women and health care workers - Slideset by Professor...
Vaccination of pregnant women and health care workers - Slideset by Professor...Vaccination of pregnant women and health care workers - Slideset by Professor...
Vaccination of pregnant women and health care workers - Slideset by Professor...WAidid
 

What's hot (20)

Vaccination in chronic children
Vaccination in chronic childrenVaccination in chronic children
Vaccination in chronic children
 
Seminar adult immunization
Seminar   adult immunizationSeminar   adult immunization
Seminar adult immunization
 
Immunisatiion during pregnancy and post partum period
Immunisatiion during pregnancy and  post partum  periodImmunisatiion during pregnancy and  post partum  period
Immunisatiion during pregnancy and post partum period
 
Chapter 36 Immunization Powerpoint
Chapter 36 Immunization Powerpoint Chapter 36 Immunization Powerpoint
Chapter 36 Immunization Powerpoint
 
Benefits of Child Vaccination
Benefits of Child Vaccination Benefits of Child Vaccination
Benefits of Child Vaccination
 
Vaccinations in pregnancy
Vaccinations in pregnancyVaccinations in pregnancy
Vaccinations in pregnancy
 
Immunizations powerpoint
Immunizations powerpointImmunizations powerpoint
Immunizations powerpoint
 
Prevention and vaccine pediatrics for clinical pharmacy
Prevention and vaccine pediatrics for clinical pharmacyPrevention and vaccine pediatrics for clinical pharmacy
Prevention and vaccine pediatrics for clinical pharmacy
 
Adult immunisation
Adult immunisationAdult immunisation
Adult immunisation
 
Vaccination and pregnancy
Vaccination and pregnancy Vaccination and pregnancy
Vaccination and pregnancy
 
Vaccinations
VaccinationsVaccinations
Vaccinations
 
Vaccination in pregnancy-DR.DIVYA JAIN
Vaccination in pregnancy-DR.DIVYA JAINVaccination in pregnancy-DR.DIVYA JAIN
Vaccination in pregnancy-DR.DIVYA JAIN
 
AAC Family Wellness (NY) - Vaccine Talk 2014
AAC Family Wellness (NY) - Vaccine Talk 2014AAC Family Wellness (NY) - Vaccine Talk 2014
AAC Family Wellness (NY) - Vaccine Talk 2014
 
immunization
immunizationimmunization
immunization
 
Priya early childhood immunization programs
Priya early childhood immunization programsPriya early childhood immunization programs
Priya early childhood immunization programs
 
Universal Immunization Program 2017
Universal Immunization Program 2017Universal Immunization Program 2017
Universal Immunization Program 2017
 
Epi seminar
Epi seminarEpi seminar
Epi seminar
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseases
 
Polio eradication program
Polio eradication programPolio eradication program
Polio eradication program
 
Vaccination of pregnant women and health care workers - Slideset by Professor...
Vaccination of pregnant women and health care workers - Slideset by Professor...Vaccination of pregnant women and health care workers - Slideset by Professor...
Vaccination of pregnant women and health care workers - Slideset by Professor...
 

Viewers also liked

Viewers also liked (7)

Minitutorial: Com inserir una imatge?
Minitutorial: Com inserir una imatge? Minitutorial: Com inserir una imatge?
Minitutorial: Com inserir una imatge?
 
Note ingenieurs
Note ingenieursNote ingenieurs
Note ingenieurs
 
The lighter pp
The lighter ppThe lighter pp
The lighter pp
 
Gp snowflakes
Gp snowflakesGp snowflakes
Gp snowflakes
 
Juniper MAG Series
Juniper MAG SeriesJuniper MAG Series
Juniper MAG Series
 
Aeterna Zentaris
Aeterna ZentarisAeterna Zentaris
Aeterna Zentaris
 
Debt Push Down
Debt Push DownDebt Push Down
Debt Push Down
 

Similar to Pox Party

When There is Risk There Must Be Choice
When There is Risk There Must Be ChoiceWhen There is Risk There Must Be Choice
When There is Risk There Must Be ChoiceRosanne Lindsay
 
Measles, Vaccines, Antibodies and Big Pharma Money
Measles, Vaccines, Antibodies and Big Pharma MoneyMeasles, Vaccines, Antibodies and Big Pharma Money
Measles, Vaccines, Antibodies and Big Pharma MoneyJohn Dewitt (LION)
 
The Reality of Antivaxx Efforts
The Reality of Antivaxx EffortsThe Reality of Antivaxx Efforts
The Reality of Antivaxx EffortsConsultant
 
Adult vaccination-turkey-ageing- need of pneumoccocal vaccination
Adult vaccination-turkey-ageing- need of pneumoccocal vaccinationAdult vaccination-turkey-ageing- need of pneumoccocal vaccination
Adult vaccination-turkey-ageing- need of pneumoccocal vaccinationkaushikawebworld
 
Auto immune disease 2015
Auto immune disease 2015Auto immune disease 2015
Auto immune disease 2015John Bergman
 
covid19-ca-alliance-vaccine-overview.pptx
covid19-ca-alliance-vaccine-overview.pptxcovid19-ca-alliance-vaccine-overview.pptx
covid19-ca-alliance-vaccine-overview.pptxravi429324
 
Vaccination2014 150420100600-conversion-gate02
Vaccination2014 150420100600-conversion-gate02Vaccination2014 150420100600-conversion-gate02
Vaccination2014 150420100600-conversion-gate02Marly0710
 
Immunization concerns
Immunization concernsImmunization concerns
Immunization concernsJina Dcruz
 
Immunization concerns revised 3-2-2011 - final [compatibility mode]
Immunization concerns   revised 3-2-2011 - final [compatibility mode]Immunization concerns   revised 3-2-2011 - final [compatibility mode]
Immunization concerns revised 3-2-2011 - final [compatibility mode]Jina Dcruz
 
Immunization concerns revised 3-2-2011 - final [compatibility mode]
Immunization concerns   revised 3-2-2011 - final [compatibility mode]Immunization concerns   revised 3-2-2011 - final [compatibility mode]
Immunization concerns revised 3-2-2011 - final [compatibility mode]Jina Dcruz
 
Changes Trend in Chickenpox - Pregnant women and prevention with vaccine Ch...
Changes Trend in Chickenpox - Pregnant women and prevention with vaccine 	 Ch...Changes Trend in Chickenpox - Pregnant women and prevention with vaccine 	 Ch...
Changes Trend in Chickenpox - Pregnant women and prevention with vaccine Ch...MedicineAndHealth14
 
Portfolio 1 16 James Winslow
Portfolio 1 16 James WinslowPortfolio 1 16 James Winslow
Portfolio 1 16 James WinslowJim Winslow
 
Dr ahmad's presentation ( Vaccine Safety )
Dr ahmad's presentation ( Vaccine Safety )Dr ahmad's presentation ( Vaccine Safety )
Dr ahmad's presentation ( Vaccine Safety )fwaseem
 
Vaccine Safety - A pediatrician perspective
Vaccine Safety - A pediatrician perspectiveVaccine Safety - A pediatrician perspective
Vaccine Safety - A pediatrician perspectiveGaurav Gupta
 
Final Slides Pedicon.pptx
Final Slides Pedicon.pptxFinal Slides Pedicon.pptx
Final Slides Pedicon.pptxDRPN1
 
Flu Vaccines....What are they good for?
Flu Vaccines....What are they good for?Flu Vaccines....What are they good for?
Flu Vaccines....What are they good for?McKinley Chiropractic
 

Similar to Pox Party (20)

Pox Parties
Pox PartiesPox Parties
Pox Parties
 
Argument 2 paper
Argument 2 paperArgument 2 paper
Argument 2 paper
 
When There is Risk There Must Be Choice
When There is Risk There Must Be ChoiceWhen There is Risk There Must Be Choice
When There is Risk There Must Be Choice
 
Measles, Vaccines, Antibodies and Big Pharma Money
Measles, Vaccines, Antibodies and Big Pharma MoneyMeasles, Vaccines, Antibodies and Big Pharma Money
Measles, Vaccines, Antibodies and Big Pharma Money
 
The Reality of Antivaxx Efforts
The Reality of Antivaxx EffortsThe Reality of Antivaxx Efforts
The Reality of Antivaxx Efforts
 
Adult vaccination-turkey-ageing- need of pneumoccocal vaccination
Adult vaccination-turkey-ageing- need of pneumoccocal vaccinationAdult vaccination-turkey-ageing- need of pneumoccocal vaccination
Adult vaccination-turkey-ageing- need of pneumoccocal vaccination
 
Auto immune disease 2015
Auto immune disease 2015Auto immune disease 2015
Auto immune disease 2015
 
covid19-ca-alliance-vaccine-overview.pptx
covid19-ca-alliance-vaccine-overview.pptxcovid19-ca-alliance-vaccine-overview.pptx
covid19-ca-alliance-vaccine-overview.pptx
 
Vaccination2014 150420100600-conversion-gate02
Vaccination2014 150420100600-conversion-gate02Vaccination2014 150420100600-conversion-gate02
Vaccination2014 150420100600-conversion-gate02
 
Vaccine Truth
Vaccine TruthVaccine Truth
Vaccine Truth
 
Immunization concerns
Immunization concernsImmunization concerns
Immunization concerns
 
Immunization concerns revised 3-2-2011 - final [compatibility mode]
Immunization concerns   revised 3-2-2011 - final [compatibility mode]Immunization concerns   revised 3-2-2011 - final [compatibility mode]
Immunization concerns revised 3-2-2011 - final [compatibility mode]
 
Immunization concerns revised 3-2-2011 - final [compatibility mode]
Immunization concerns   revised 3-2-2011 - final [compatibility mode]Immunization concerns   revised 3-2-2011 - final [compatibility mode]
Immunization concerns revised 3-2-2011 - final [compatibility mode]
 
Changes Trend in Chickenpox - Pregnant women and prevention with vaccine Ch...
Changes Trend in Chickenpox - Pregnant women and prevention with vaccine 	 Ch...Changes Trend in Chickenpox - Pregnant women and prevention with vaccine 	 Ch...
Changes Trend in Chickenpox - Pregnant women and prevention with vaccine Ch...
 
Portfolio 1 16 James Winslow
Portfolio 1 16 James WinslowPortfolio 1 16 James Winslow
Portfolio 1 16 James Winslow
 
Dr ahmad's presentation ( Vaccine Safety )
Dr ahmad's presentation ( Vaccine Safety )Dr ahmad's presentation ( Vaccine Safety )
Dr ahmad's presentation ( Vaccine Safety )
 
Vaccine Safety - A pediatrician perspective
Vaccine Safety - A pediatrician perspectiveVaccine Safety - A pediatrician perspective
Vaccine Safety - A pediatrician perspective
 
Final Slides Pedicon.pptx
Final Slides Pedicon.pptxFinal Slides Pedicon.pptx
Final Slides Pedicon.pptx
 
Flu Vaccines...What Good Are They?
Flu Vaccines...What Good Are They?Flu Vaccines...What Good Are They?
Flu Vaccines...What Good Are They?
 
Flu Vaccines....What are they good for?
Flu Vaccines....What are they good for?Flu Vaccines....What are they good for?
Flu Vaccines....What are they good for?
 

Pox Party

  • 1. A dangerous trend in the USA 1
  • 2. Headache Fever Blisters Tiredness Itching Chicken pox Sore (Varicella) throat 22 http://www.cdc.gov
  • 4. USA - Before 1995 Each year 4 million people would get the chicken pox About 10,500 – 13,000 were hospitalized Majority : healthy children and 100 to 150 died adults http://www.cdc.gov 4 Walter A., Orenstein M.D., National Immunization Program. Overview of the US Vaccination Program
  • 5. Why a VZV vaccine? Varicella develops in nearly all persons living in the US • > 90% of adults immune to VZV Complications rate higher for persons ≥ 15 and < 1 years of age • Bacterial infection of skins lesions, pneumonia, dehydratation, encephalitis, hepatitis VZV vaccine licensed in several European countries (1984), Japan (1986), Korea (1988) • No safety concerns after the administration of > 2 million doses in these countries Varicella is less severe among vaccinated persons than unvaccinated persons • Afebrile, fewer vesicular lesions, shorter duration of illness Difference of incidence of herpes zoster • 18 per 100000 persons/year for vaccinated people • 77 per 100000 persons/year after natural Varicella 5 MMWR, Advisory Committee on Immunization Practices (ACIP). Prevention of Varicella. July 12, 1996, Vol 45, No RR-11
  • 6. Cost-effectiveness of a Routine Varicella Vaccination program for US children One dose/child under 6 30-year period following introduction $35/dose At school entry, vaccination coverage level = 97% by the 6th year Medical costs Work-loss costs • Varicella treatment : Acyclovir • Parents missing work when their children • Vaccinated people : no Acyclovir have the chickenpox ($201) • Complications • Adults contracting chickenpox Taking into account • Evidence about vaccine efficacy • Effects of expected changes in the age distribution of the disease • Empirical data on the costs of medical utilization and work loss from varicella 6 Lieu, Tracy A et al. Cost-effectiveness of a Routine Varicella Vaccination program for US Children. JAMA; 1994; 271 (5), 375-381
  • 7. Cost-effectiveness of a Routine Varicella Vaccination program for US children 7 Lieu, Tracy A et al. Cost-effectiveness of a Routine Varicella Vaccination program for US Children. JAMA; 1994; 271 (5), 375-381
  • 8. Cost-effectiveness of a Routine Varicella Vaccination program for US children Savings from Varicella disease prevention : $1.3 billion for the 1-dose program, $1.4 billion for the 2-dose program. 8 Lieu, Tracy A et al. Cost-effectiveness of a Routine Varicella Vaccination program for US Children. JAMA; 1994; 271 (5), 375-381
  • 9. 99
  • 10. Recommendation map Kg: Kindergarten Gr: School Grade
  • 11. Effects of vaccination Hospitalization rate: 2.2 to 3.3/100.000 (1995-1998) to 0.5/100.000 (2004) Death rate: 0.41 deaths/1,000,000 (1990-1994) to 0.14 (1999-2001) (decrease of 78%)
  • 12. The other hand FEAR Not natural Side effects •Mild : fever (≤1/10), rash (1/25) •Moderate: Seizure (jerking/staring) caused by fever (very rare) •Severe: pneumonia
  • 13. The French point of view Same incidence, same complications, same risks… BUT vaccine only recommended in certain cases, if no varicella history: •Vaccination within 3 days following exposure (adults & immunocompetent) •Health care workers •Contact with young children & immunodeficient people •Children organ recipient Considering that: 15 years of vaccine coverage of children of 11 years-old is necessary to save: •1 death •30 severe complications •30.000 cases/year (nowadays incidence is about 600.000 cases/year) Plus: •increasing of the disease in the teenage and adult population •Increasing of zoster outcomes in the senior population. HAS: AVIS DU CONSEIL SUPÉRIEUR D'HYGIÈNE PUBLIQUE DE FRANCE SECTION MALADIES TRANSMISSIBLES Relatif à la vaccination contre la varicelle
  • 14. “ils sont fous ces américains” New drifts : Mailing/selling infected clothes, saliva samples, infected lollipops... Risk of 20 years of imprisonment: under biohazard regulation (like anthrax) Danger for workers of mailing companies Looking for more dangerous diseases: Measles, mumps…